Biosurgery Market Promising Trends with $26.25 Billion, Global Analysis on Recent Developments and Forecast

Biosurgery is a surgical process that uses natural and artificial surgical tools. By soaking up fluids and sealing the wound, these products isolate the injuries and stop blood loss. Using these products will help shorten the recovery period after surgery and address problems related to surgery. The biosurgery market worth in 2021 was USD 15.93 billion, and it will be USD 26.25 billion with a 5.7% CAGR.

Biosurgery Market Insights

  • In the year 2020, the market was ruled by the surgical sealants segment on the basis of product type.
  • On the basis of surgery, the General surgery segment was the largest market growing at a rapid 8.6% CAGR in 2020.
  • The hospital segment was the biggest market in 2020 in terms of end-user.
  • North America ruled the market for biosurgery with a share of nearly 32% regionally.

Biosurgery Market Dynamics

Due to the increasing aging population and an increase in sports-related injuries, the global biosurgery market is expanding significantly. The market is also expanding due to the rising prevalence of chronic diseases like cardiovascular disease, infectious diseases, diabetes mellitus, cancer, autoimmune diseases, and nephrological diseases. Opportunities for the producers of biosurgery products will arise from the rapid growth of emerging economies. The main obstacle to the expansion of the global market is the lack of reimbursement and the huge cost of these products.

Biosurgery Market Segmentation

The worldwide Biosurgery Market segmentation has been initiated on the basis of product type, End-user, application, and region.

By Product:

  • Staple-Line Reinforcement Agents
  • Soft tissue attachments
  • Biological meshes
  • Allografts
  • Xenografts
  • Synthetic meshes

β€’ Bone Graft Substitutes

  • Bone Morphogenetic Proteins
  • Synthetic Bone Grafts
  • Demineralized bone matrix
  • Other Bone-Graft Substitutes

 β€’ Hemostatic agents

  • Combination hemostatic agents
  • Thrombin based hemostatic agents
  • Oxidized regenerated cellulose based hemostatic agents

β€’ Surgical sealants and adhesives

  • Natural/Biological Sealants and Adhesives
  • Gelatin
  • Fibrin 
  • Collagen
  • Albumin
  • Others
  • Synthetic and Semi-Synthetic Sealants and Adhesives
  • Urethane Based Sealants and Adhesives
  • Cyanoacrylate Based Sealants and Adhesives
  • Peg Hydrogels
  • Other 

β€’ Adhesion Barriers

  • Synthetic Adhesion Barriers
  • Peg-Based Adhesion Barriers
  • Other Synthetic Adhesion Barriers
  • Hyaluronic Acid Based Adhesion Barriers
  • Regenerated Cellulose Based Adhesion Barriers
  • Natural Adhesion Barriers
  • Collagen & Protein Adhesion Barriers
  • Fibrin-Based Adhesion Barriers

By surgery:

  • Reconstructive Surgery
  • Urological Surgery
  • Gynecological Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Thoracic Surgery
  • Others

By End-User

  • Clinics
  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

North America

  • Canada
  • Mexico
  • United States
  • Rest of North America


  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • South Korea
  • China
  • Australia
  • Japan
  • India
  • Rest of Asia Pacific


  • Saudi Arabia
  • Argentina
  • Uruguay
  • Brazil
  • Rest of LAMEA

On the basis of surgery, the general surgery segment was the largest market growing at a rapid 8.6% CAGR in 2020. The overall growth of this market is being fuelled by elements like the acceleration of technological development and the rising popularity of technologically skilled surgeries in emerging economies.

North America ruled the market for biosurgery with a share of nearly 32% regionally. Strong medical infrastructure and simple public funding disbursement policies are to blame. Countries like the USA and Canada also encourage financial investment in R&D-related activities to create cutting-edge products.

Key players in Biosurgery Market:

  • Hemostasis LLC.
  • Pfizer Inc.
  • Cyrolife Inc. 
  • Medtronic Plc
  • Integra Lifesciences Holdings Corp. 
  • CSL Ltd.
  • Zimmer Biomet
  • Stryker Corp.
  • Orthofix Medical Inc.
  • Kuros Biosciences AG
  • Johnson and Johnson
  • Becton, Dickinson & Co.
  • Tissue Regenix Group Plc  
  • Smiths & Nephew Plc.
  • Tissue Regenix Group Plc 
  • Betatech Medical 
  • Meril Lifesciences Pvt. Ltd.
  • RTI Surgicals 
  • Samyang Holdings Corp. 

The biosurgery market will grow at a rapid 5.7% CAGR, and by 2030 it will reach USD 26.25 billion. The rise in the elderly population, an increase in sports-related injuries and surgeries, a rise in the approval of biosurgery products, a rise in the demand for effective patient blood loss management, and other factors accelerate the growth of the market.

Leave a Comment

Your email address will not be published. Required fields are marked *